Researchers are testing an investigational medicine called ALZ-507 in healthy adults between 50 and 75 years of age. The purpose of this study is to learn: A…

Healthy Participants Study

~Estimated

~$10 – $8,750

Alzheon Inc.NCT07824271

Phase 1

Neural Effects of Continuous Intravenous Infusion of N,N-dimethyltryptamine (DMT)

This study examines how the psychedelic substance DMT affects the human brain when administered by the intravenous (IV) route. DMT is a naturally occurring che…

Healthy Participants Study

A Phase 1, Randomized, Double-Blind, Sponsor-Open, Placebo Controlled, First in Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of Single Ascending and Multiple Doses of PRX019 in Healthy Adults

The purpose of this study is to assess the safety and tolerability of PRX019 in healthy adult participants.

Healthy Participants Study

~Estimated

~$10 – $8,750

Prothena Biosciences Ltd.NCT06699680